Anti-dystrophin antibodies are crucial for Western blot analysis in Duchenne muscular dystrophy (DMD) research, enabling detection, quantification, and therapeutic validation of dystrophin restoration. These antibodies help measure protein levels following exon-skipping, gene therapy, and other treatments. Standardizing antibody specificity and sensitivity ensures reliable dystrophin quantification, driving consistent, reproducible results in DMD therapy evaluation and biomarker research.

more